• Forum
  • Aktiemarkeder
    • MarkederRealtidskurser, indekser og markedsudvikling
    • BørskalenderKommende resultater, noteringer og virksomhedsbegivenheder
    • UdbyttekalenderKommende og tidligere udbytter
  • Selskaber
    • SelskaberGennemse og filtrer den fulde liste over børsnoterede selskaber
    • OpdagInspiration til din næste investering
    • BørsnoteringerNye noteringer og kommende børsintroduktioner
    • Invitationer til generalforsamlingerDatoer for generalforsamlinger og aktionærinformation
  • Aktieanalyse
    • ResearchEkspertaktieanalyse og anbefalinger
    • ArtiklerNyheder, indsigter og markedskommentarer
    • inderesTVVideocenter for aktieanalyse, forskning og ekspertkommentarer
    • TransskriptionerFuldstændige udskrifter af resultatopkald og investormøder
    • AktieoversigtSammenlign nøgletal og udvikling på tværs af flere aktier
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer

Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.

Analyse

Scanfil extensive report: Good quality with full short-term pricing

Af Antti ViljakainenHead of Research
Scanfil
Download analyse (PDF)

Oversigt

  • The target price for Scanfil has been raised to EUR 12.50 due to slightly increased long-term growth estimates, although the short-term expected return is narrowed by recent share price progress.
  • Scanfil, a global electronics contract manufacturer, benefits from a comprehensive factory network and a strong financial history, with risks primarily from the global economy and investment-driven demand.
  • The company is expected to see revenue and EBIT growth this year, driven by acquisitions and organic growth, with a projected annual revenue growth rate of 5-8% in the coming years.
  • Scanfil's valuation has risen in the short term, with current-year multiples 20-30% above its 5-year medians, making the short-term valuation challenging despite good long-term growth prospects.

This content is generated by AI. You can give feedback on it in the Inderes forum.

Translation: Original published in Finnish on 6/17/2026 at 3:15 am EEST.

We raise our target price for Scanfil to EUR 12.50 (was 11.50 €) on the heels of slightly increased long-term growth estimates. Scanfil has made good progress in recent years in executing its playbook, which relies on organic growth and acquisitions, and we expect this tactic to continue driving the company's profitable growth. Following the robust progress of the share price over the past year, the positive earnings growth projected in our forecasts has already been factored into the share. In our view, this narrows Scanfil's short-term expected return, even though the long-term story remains quite attractive.

Scanfil is a global electronics contract manufacturer

Scanfil offers its customers the opportunity to outsource the manufacture of products containing electronics and focus on their core operations, which creates flexibility in cost structures and improves capital efficiency for customers. Scanfil manufactures end products especially for the industrial, energy and environmental sectors (green transition), the healthcare segment, and the defense sector. In these customer segments, small production batches, short delivery times and long product cycles enable smaller companies to operate viably, even though competition in the industry is tight. The company has a total of 16 factories divided into the geographical areas of Central Europe, Northern Europe, APAC and the Americas. We believe that Scanfil's strengths include its comprehensive factory network, global operating model, cost-efficient culture, and extensive industry experience. The company also has a strong financial history, which reflects the viability of Scanfil's strategy over time. In our view, the clearest risks for Scanfil stem from the global economy and investment-driven demand.

Scanfil is a growth company, and the earnings growth outlook is currently good

We estimate that the relevant market volumes of Scanfil will grow faster than GDP in the long term. This growth is leveraged by the increasing outsourcing rate of industrial production, electrification, defense investments, and the relocation of certain supply chains closer to Western end-product markets. The company's market is fragmented, which gives Scanfil a good platform for inorganic growth. In the past nearly 2 years, the company has completed 3 acquisitions that expanded Scanfil’s customer base and geographic reach and established a foothold in the defense sector with strong medium-term prospects. Furthermore, despite generally sluggish market conditions in recent years, the company has managed to boost its sales, particularly among large customers, which has so far been reflected especially in strong sales figures for new projects.

We expect the company's revenue and EBIT to step up this year due to the MB and ADCO acquisitions and slight organic growth.  We estimate that revenue will grow at an annual rate of 5-8% in the coming years, driven by new projects and the positive development of underlying demand. We expect profitability (adj. /comp. EBITA %) to slowly improve with growth and rise towards the upper end of the 7-8% target range as growth scales slightly. In fact, according to our forecasts, the company's earnings are set to grow significantly by 2028.

Valuation has risen in the short term

Based on our estimates for 2026 and 2027, Scanfil's adjusted P/E ratios are 17x and 15x, while the corresponding EV/EBITA ratios are 13x and 12x. The current-year multiples, which are the main focus, are 20–30% above the company's own 5-year medians. Correspondingly, the expected annual return, consisting of earnings growth, downside in multiples (Q1’26 LTM P/E 19x), and a dividend yield of just over 2%, remains modest. Considering our DCF value, the share valuation is also somewhat tight. Scanfil is relatively undervalued by approximately 20–30% compared to global contract manufacturers and rather neutrally valued relative to Nordic peers. However, the global peer group is expensive by historical standards. Thus, we find the share's short-term valuation picture already quite challenging, even though the company has good long-term prospects, especially for growth-driven value creation.

Scanfil is an international electronics contract manufacturer, specializing in industrial and B2B customers. Services include manufacturing of end products and components such as PCBs. Manufacturing services are the core of the company, supported by design, supply chain and modernization services. The company operates globally in Europe, America and Asia. Customers are primarily found in the process automation, energy efficiency, green efficiency and medical segments.

Læs mere på virksomhedsside

Key Estimate Figures16.06

202526e27e
Omsætning797,1993,11.060,2
vækst-%2,2 %24,6 %6,8 %
EBIT (adj.)56,472,680,9
EBIT-% (adj.)7,1 %7,3 %7,6 %
EPS (adj.)0,650,780,89
Udbytte0,250,270,29
Udbytte %2,5 %2,0 %2,2 %
P/E (adj.)15,417,115,0
EV/EBITDA8,510,09,3

Forumopdateringer

Antti har som flittig chefanalytiker udarbejdet en omfattende analyse af Scanfil. Som det gør sig gældende for andre dybdegående analyser, er...
for 10 timer siden
af Sijoittaja-alokas
7
Ny PRESSEmeddelelse fra Scanfil Scanfil styrker sit samarbejde med AXS-divisionen, som er en del af Brukers Life Science & Medtech-forretning...
19.5.2026, 08.49
af Sijoittaja-alokas
5
Hej, den kommer til salg i Suomalainen kirjakauppa, og derudover vil der være tre eksemplarer til udlån på Sievi bibliotek.
18.5.2026, 09.37
af Pasi Hiedanpää
4
Hej Pasi! Er det muligt at få fat i dette 50-års jubilæumsværk på et senere tidspunkt, hvis man ikke har mulighed for at komme på messen nu?
18.5.2026, 06.42
af JNivala
4
Du kan finde mig og Scanfil Group på denne uges investeringsmesse i Tampere! Kig forbi vores stand B37, så fortæller vi, hvorfor Scanfil Oyj...
18.5.2026, 06.32
af Pasi Hiedanpää
10
Her er Nordeas seneste tanker om Scanfil Vi opjusterer vores fair value-interval for Scanfil til EUR 11,2-13,7 (10,4-12,7). Dets hårde arbejde...
16.5.2026, 22.23
af Sijoittaja-alokas
9
Her er Anttis kommentarer til Scanfils nye kontrakt. Scanfil meddelte onsdag, at de har indgået en samarbejdsaftale med en førende virksomhed...
15.5.2026, 04.54
af Sijoittaja-alokas
9